NASDAQ · Analyst Forecast

Regencell Bioscience Holdings Limited (RGC) Stock Forecast & Price Target

$4.62 NASDAQ: RGC Market Cap $2.29B

Price as of Nov 17, 2026 (intraday, delayed) · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Regencell Bioscience Holdings Limited (RGC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

No analyst estimates are published for this stock. Coverage is concentrated in larger companies.

Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks

TEVA forecastZTS forecastVTRS forecastELAN forecastRDY forecastALKS forecastAMRX forecastLNTH forecastSUPN forecastBHC forecastAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.